Which of the following is a key advantage of case-control studies compared to cohort studies in epidemiological research?

## Comparative Advantages: Case-Control vs Cohort Studies **Key Point:** Case-control studies are retrospective and therefore ideal for investigating **rare diseases** because they start with affected individuals (cases) rather than waiting for disease to develop in a cohort. ### Why Case-Control Studies Excel for Rare Diseases **Problem with Cohort Studies for Rare Diseases:** - To study a rare disease (e.g., mesothelioma, hepatic angiosarcoma), a cohort study would require an enormous sample size - Example: If disease incidence is 1 per 100,000 per year, a cohort of 100,000 might yield only 1 case per year - This makes cohort studies **impractical and prohibitively expensive** for rare outcomes **Advantage of Case-Control Studies:** - Start with **already-affected individuals** (cases) and controls - No need to wait for disease development - Smaller sample size required - Much lower cost and faster completion - Can investigate multiple exposures retrospectively ### Comparison Table | Feature | Cohort Study | Case-Control Study | |---------|-------------|-------------------| | **Time direction** | Prospective (exposure → disease) | Retrospective (disease → exposure) | | **Measure of association** | Relative Risk (RR) | Odds Ratio (OR) | | **Ideal for** | Common diseases, establishing causation | Rare diseases, hypothesis generation | | **Cost** | High (long follow-up) | Low (quick, retrospective) | | **Sample size for rare disease** | Very large (impractical) | Manageable | | **Bias risk** | Loss to follow-up, attrition | Recall bias, selection bias | **High-Yield:** Case-control studies are the **gold standard** for investigating rare diseases because they are efficient and cost-effective. Cohort studies are preferred for common diseases and establishing temporal causation. **Mnemonic:** **RARE** = Retrospective Analysis Reveals Efficiency (case-control for rare diseases).